Advisors Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Advisors Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,102	Closed	-$393K	–	1928
2015 Q3	$393K	Buy	9,102 +2,065	+29%	+$87.1K	0.01%	1160
2015 Q2	$297K	Buy	7,037 +1,118	+19%	+$47.1K	﹤0.01%	1273
2015 Q1	$230K	Buy	5,919 +1,587	+37%	+$61.1K	﹤0.01%	1306
2014 Q4	$146K	Sell	4,332 -674	-13%	-$23.8K	﹤0.01%	1391
2014 Q3	$175K	Buy	5,006 +286	+6%	+$9.8K	﹤0.01%	1308
2014 Q2	$155K	Buy	4,720 +1,854	+65%	+$63.4K	﹤0.01%	1353
2014 Q1	$106K	Buy	+2,866	New	+$105K	﹤0.01%	1427
2013 Q3	–	Sell	-4,677	Closed	-$98K	–	1822
2013 Q2	$98K	Buy	+4,677	New	+$91.3K	﹤0.01%	1303

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Advisors Asset Management's WX Position: Q4 2015 in Review

Advisors Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 9,102 shares — an estimated $393K sold.

Advisors Asset Management first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $393K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Advisors Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Advisors Asset Management sold 9,102 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $393K.
Advisors Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
Advisors Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $393K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Advisors Asset Management's 13F filing for Q4 2015, filed 10 Feb 2016.